Cardiovascular disease biomarkers across autoimmune diseases

Joseph Ahearn1, Kelly J Shields1, Chau-Ching Liu1

  • 1Lupus Center of Excellence, Autoimmunity Institute, Department of Medicine, Allegheny Health Network, USA.

Insights

Patients with autoimmune disease face high risks of cardiovascular disease (CVD). New biomarkers help identify at-risk individuals for better prevention and treatment strategies.

Area of Science:

  • Immunology
  • Cardiology
  • Biomarker Discovery

Background:

  • Autoimmune diseases significantly increase the risk of premature cardiovascular disease (CVD) mortality.
  • Early identification of high-risk patients with autoimmune disorders is crucial for timely intervention and prevention.
  • Current diagnostic tools may not fully capture the complex CVD risk in these populations.

Purpose of the Study:

  • To review recent advancements in cardiovascular disease biomarkers relevant to patients with autoimmune disorders.
  • To highlight the potential clinical utility of these biomarkers for risk stratification and management.
  • To discuss the role of biomarkers in accelerating targeted therapies for CVD in autoimmunity.

Main Methods:

  • Literature review of recent studies on cardiovascular disease biomarkers in autoimmune diseases.
  • Focus on lipid oxidation, imaging biomarkers (coronary calcium, plaque, intima media thickness), inflammation, complement, genetic, endothelial, and antiphospholipid antibody markers.
  • Analysis of the clinical implementation and therapeutic implications of these biomarkers.

Main Results:

  • Emerging biomarkers include lipid oxidation products, imaging assessments of atherosclerosis, inflammatory markers, complement activation products, genetic predispositions, endothelial dysfunction indicators, and antiphospholipid antibodies.
  • These biomarkers offer a more comprehensive approach to assessing CVD risk in autoimmune disease.
  • Successful clinical implementation can improve patient care and drug development.

Conclusions:

  • A panel of diverse biomarkers is essential for accurate identification, monitoring, and stratification of cardiovascular risk in autoimmune disease patients.
  • Implementing these biomarkers can enhance clinical decision-making and personalize treatment strategies.
  • Further research and clinical validation will facilitate the reduction of cardiovascular mortality in individuals with autoimmune conditions.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
771
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
2.2K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.1K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
767